194 related articles for article (PubMed ID: 22234703)
1. Survivin in solid tumors: rationale for development of inhibitors.
Church DN; Talbot DC
Curr Oncol Rep; 2012 Apr; 14(2):120-8. PubMed ID: 22234703
[TBL] [Abstract][Full Text] [Related]
2. First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meeting.
Molckovsky A; Siu LL
J Hematol Oncol; 2008 Oct; 1():20. PubMed ID: 18959794
[TBL] [Abstract][Full Text] [Related]
3. Targeting survivin in cancer: novel drug development approaches.
Groner B; Weiss A
BioDrugs; 2014 Feb; 28(1):27-39. PubMed ID: 23955284
[TBL] [Abstract][Full Text] [Related]
4. Dual Targeting of Anti-Apoptotic Proteins Enhances Chemosensitivity of the Acute Myeloid Leukemia Cells.
Baradaran B; Nazmabadi R; Ariyan Z; Sakhinia E; Karami H
Asian Pac J Cancer Prev; 2022 Jul; 23(7):2523-2530. PubMed ID: 35901361
[TBL] [Abstract][Full Text] [Related]
5. Role of autophagy in drug resistance and regulation of osteosarcoma (Review).
Pu Y; Wang J; Wang S
Mol Clin Oncol; 2022 Mar; 16(3):72. PubMed ID: 35251623
[TBL] [Abstract][Full Text] [Related]
6. Shikonin Inhibits Non-Small-Cell Lung Cancer H1299 Cell Growth through Survivin Signaling Pathway.
Wang H; Zuo J
Anal Cell Pathol (Amst); 2021; 2021():6435393. PubMed ID: 34782853
[TBL] [Abstract][Full Text] [Related]
7. In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells.
Wanandi SI; Limanto A; Yunita E; Syahrani RA; Louisa M; Wibowo AE; Arumsari S
PLoS One; 2020; 15(11):e0240020. PubMed ID: 33211707
[TBL] [Abstract][Full Text] [Related]
8. On the discovery of a potential survivin inhibitor combining computational tools and cytotoxicity studies.
Quispe PA; Lavecchia MJ; León IE
Heliyon; 2019 Aug; 5(8):e02238. PubMed ID: 31440594
[TBL] [Abstract][Full Text] [Related]
9. Exosomal survivin facilitates vesicle internalization.
Gonda A; Kabagwira J; Senthil GN; Ferguson Bennit HR; Neidigh JW; Khan S; Wall NR
Oncotarget; 2018 Oct; 9(79):34919-34934. PubMed ID: 30405884
[TBL] [Abstract][Full Text] [Related]
10. The role of miRNAs 34a, 146a, 320a and 542 in the synergistic anticancer effects of methyl 2-(5-fluoro-2-hydroxyphenyl)-1H- benzo[d]imidazole-5-carboxylate (MBIC) with doxorubicin in breast cancer cells.
Hasanpourghadi M; Abdul Majid N; Rais Mustafa M
PeerJ; 2018; 6():e5577. PubMed ID: 30245930
[TBL] [Abstract][Full Text] [Related]
11. Epithelial TNF Receptor Signaling Promotes Mucosal Repair in Inflammatory Bowel Disease.
Bradford EM; Ryu SH; Singh AP; Lee G; Goretsky T; Sinh P; Williams DB; Cloud AL; Gounaris E; Patel V; Lamping OF; Lynch EB; Moyer MP; De Plaen IG; Shealy DJ; Yang GY; Barrett TA
J Immunol; 2017 Sep; 199(5):1886-1897. PubMed ID: 28747340
[TBL] [Abstract][Full Text] [Related]
12. Targeting mitotic pathways for endocrine-related cancer therapeutics.
Agarwal S; Varma D
Endocr Relat Cancer; 2017 Sep; 24(9):T65-T82. PubMed ID: 28615236
[TBL] [Abstract][Full Text] [Related]
13. Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of Survivin.
Xu Y; Wang S; Chan HF; Lu H; Lin Z; He C; Chen M
Sci Rep; 2017 Apr; 7():46060. PubMed ID: 28436480
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol.
Vogl TJ; Oppermann E; Qian J; Imlau U; Tran A; Hamidavi Y; Korkusuz H; Bechstein WO; Nour-Eldin NE; Gruber-Rouh T; Hammerstingl R; Naguib NN
BMC Cancer; 2016 May; 16():325. PubMed ID: 27215551
[TBL] [Abstract][Full Text] [Related]
15. Epithelial PIK3R1 (p85) and TP53 Regulate Survivin Expression during Adaptation to Ileocecal Resection.
Cohran V; Managlia E; Bradford EM; Goretsky T; Li T; Katzman RB; Cheresh P; Brown JB; Hawkins J; Liu SXL; De Plaen IG; Weitkamp JH; Helmrath M; Zhang Z; Barrett TA
Am J Pathol; 2016 Jul; 186(7):1837-1846. PubMed ID: 27157990
[TBL] [Abstract][Full Text] [Related]
16. Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis.
Duan L; Hu X; Jin Y; Liu R; You Q
BMC Cancer; 2016 Apr; 16():276. PubMed ID: 27090386
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of skeletal growth of human prostate cancer by the combination of docetaxel and BKM1644: an aminobisphosphonate derivative.
Zhang S; Gera L; Mamouni K; Li X; Chen Z; Kucuk O; Wu D
Oncotarget; 2016 May; 7(19):27489-98. PubMed ID: 27050371
[TBL] [Abstract][Full Text] [Related]
18. T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to Carboplatin.
Dziegielewska B; Casarez EV; Yang WZ; Gray LS; Dziegielewski J; Slack-Davis JK
Mol Cancer Ther; 2016 Mar; 15(3):460-70. PubMed ID: 26832797
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy.
Rodríguez-Berriguete G; Torrealba N; Ortega MA; Martínez-Onsurbe P; Olmedilla G; Paniagua R; Guil-Cid M; Fraile B; Royuela M
BMC Cancer; 2015 Oct; 15():809. PubMed ID: 26507126
[TBL] [Abstract][Full Text] [Related]
20. Survivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasion.
Rivadeneira DB; Caino MC; Seo JH; Angelin A; Wallace DC; Languino LR; Altieri DC
Sci Signal; 2015 Aug; 8(389):ra80. PubMed ID: 26268608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
